www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

NAZ2329

Catalogue number:
HY-103693-5mg
Supplier:
Size:
5 mg
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£498.00 Shipping is calculated in checkout
This product is for research use only and is not for human consumption or therapeutic use.
CAS Number:

2809469-05-2

Purity:

99.57

Molecular Weight:

501.56

Product Description:

NAZ2329, the first cell-permeable inhibitor of R5 subfamily of receptor-type protein tyrosine phosphatases (RPTPs), allosterically and preferentially inhibits PTPRZ (IC50=7.5 µM for hPTPRZ1) and PTPRG (IC50=4.8 µM for hPTPRG) over other PTPs. NAZ2329 binds to the active D1 domain and more potently inhibits PTPRZ-D1 fragment (IC50 of 1.1 µM) than the whole intracellular (D1 + D2) fragment (IC50 of 7.5 µM). NAZ2329 can effectively inhibit tumor growth of the glioblastoma cells and suppress stem cell-like properties[1].

Storage Temperature:

-20°C, 3 years; 4°C, 2 years (Powder)

Details Cat number & supplier Size Price
GW604714X HY-138559-5mg · MedChem Express
HY-138559-5mg
MedChem Express
5 mg £435.00
5 mg
view
WNK-IN-11-d3 HY-112094S-5mg · MedChem Express
HY-112094S-5mg
MedChem Express
5 mg £932.00
5 mg
view
9-Methoxycamptothecin HY-N6011-5mg · MedChem Express
HY-N6011-5mg
MedChem Express
5 mg £32.00
5 mg
view
Afatinib impurity 11 HY-133780-5mg · MedChem Express
HY-133780-5mg
MedChem Express
5 mg £324.00
5 mg
view
10-Methoxycamptothecin HY-N0446-5mg · MedChem Express
HY-N0446-5mg
MedChem Express
5 mg £149.00
5 mg
view
Hibifolin HY-N7368-5mg · MedChem Express
HY-N7368-5mg
MedChem Express
5 mg £187.00
5 mg
view
6-Methoxydihydrosanguinarine HY-N3000-5mg · MedChem Express
HY-N3000-5mg
MedChem Express
5 mg £684.00
5 mg
view
Neoglycyrol HY-N3961-5mg · MedChem Express
HY-N3961-5mg
MedChem Express
5 mg £466.00
5 mg
view
AG-636 HY-137463-5mg · MedChem Express
HY-137463-5mg
MedChem Express
5 mg £249.00
5 mg
view
Zeylenone HY-N2051-5mg · MedChem Express
HY-N2051-5mg
MedChem Express
5 mg £1065.00
5 mg
view